N2Growth Blog

FEBRUARY 4, 2015

A move toward the Advantage Strategy Paradigm begins with the adoption and commitment to a set of principles that guides all executives in the decisions and actions they take related to developing, planning, and executing strategy. Collaborative and Co-created. Focus on Advantage.

Process 150

Process Agility Competitive Advantage Strategy 150

Great Leadership By Dan

MAY 22, 2014

Author Bio: Robert Bruce Shaw , author of Leadership Blindspots: How Successful Leaders Identify and Overcome the Weaknesses That Matter , works with senior executives on the management of strategic organizational change and leadership development. Robert holds a Ph.D. degree in organizational behavior from Yale University.

Shaw 229

Shaw Telecommunications Metrics Pharmaceuticals 229

Marshall Goldsmith

NOVEMBER 7, 2011

A: In my work as an executive coach, I only get paid if my clients achieve a positive, lasting change in behavior - not as judged by themselves, but as determined by their key stakeholders. The huge majority of professionals who call themselves executive coaches are actually behavioral coaches. We even hired an executive coach."

Executive Coaching 126

Executive Coaching Govindarajan Prahalad Leadership 126

Marshall Goldsmith

FEBRUARY 8, 2018

Authority on new technology and communication. Teaches leadership to executives and emerging leaders around the world. Former Chairman and Chief Executive Officer Global Debt Registry (MHR). Corporate Executives. Former Executive VP and Head of Strategy & Transformation at TMB Bank.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Tanveer Naseer

MARCH 10, 2015

Most senior executives respond to this question by describing what the company is or what it does. For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” technology, infrastructure, data—does our company (or our value network) currently own?

How To 100

How To Retail Core Competence Innovation 100

Harvard Business Review

MAY 7, 2015

Recently, information technology research and advisory company Gartner compiled a list of top 10 strategic technology trends. In the pharmaceutical industry, technology is transforming the sales process. In the pharmaceutical industry, technology is transforming the sales process. Computing everywhere.

Trends 8

Trends Technology Pharmaceuticals Team 8

Strategy Driven

NOVEMBER 29, 2016

Always at the forefront of innovation, technologies pioneered by the military are often adopted by the commercial sector; companies looking for cyber knowledge or network engineering skills can find this expertise among veterans. Bill Sebra is Chief Operations Executive at Korn Ferry Futurestep. About the Author.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Strategy Driven

JULY 13, 2011

Since the unit’s reported financial results were so good, the executives at the corporate headquarters didn’t ask many questions about the drivers of the unit’s profits – until it was too late. Some examples include new technologies, changes in customer preferences, new ways of serving customers, and disruptive threats.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

APRIL 19, 2016

Carmakers have started using 3D technology to produce parts. Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. The technology is expected to lead to reductions in the cost of employment, capital investment, shipping and inventory as well. Threat analysis.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

APRIL 7, 2015

There are new types of insurance companies such as Oscar ; novel provider organizations such as OneMedical , IoraHealth , and ChenMed ; and new health information technology companies such as Castlight , Vital , and WellFrame that aim to use technology to improve care and value. It would be a shame if they did.

Execution 8

Execution Skills Health Care Porter 8

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. The following is a guest post by Russell Bishop.

Bureaucracy 203

Bureaucracy Compliance Learning-by-Doing Engineering 203

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. In addition, many top pharma customers (payers, etc.)

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

The Horizons Tracker

NOVEMBER 29, 2023

“Noting the benefits of diverse experiences in the board room, corporate executives can search beyond the tradition director pedigree (e.g. Moderna, a prominent pharmaceutical and biotechnology firm, adopted an unconventional approach utilizing RNA technology to develop one of the COVID-19 vaccines.

Diversity 101

Diversity Innovation Biotechnology Short-term 101

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

AUGUST 14, 2018

The term “digital firms” refers to those companies that from their inception have focused on digital services enabled by the internet and related technologies, including mobile. imposing technological platforms developed for the U.S. ” remarked a former senior executive from eBay. market on China.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

The Recovering Engineer

FEBRUARY 27, 2010

I am not a doctor, pharmacist, attorney, drug company executive or any other person who has deep insights into the intricacies of our health care system. We have state-of-the-art medical technology available, IF a person can pay for it. And, frankly, it makes me sick. has a great doctor/patient and nurse/patient ratio.

Health Care 102

Health Care Engineering System Politics 102

The Recovering Engineer

FEBRUARY 27, 2010

I am not a doctor, pharmacist, attorney, drug company executive or any other person who has deep insights into the intricacies of our health care system. We have state-of-the-art medical technology available, IF a person can pay for it. And, frankly, it makes me sick. has a great doctor/patient and nurse/patient ratio.

Health Care 102

Health Care Engineering System Politics 102

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. Recruiting directors with technological expertise is one avenue through which boards can boost their innovative capabilities. Jason Jaroslav Cook Creative/Getty Images.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

AUGUST 3, 2012

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. Historically, big pharma firms made their own drugs.

Licensing 12

Licensing Depreciation Pharmaceuticals Budgeting 12

Harvard Business Review

NOVEMBER 9, 2011

The answers may not be as self-evident as many executives think. Of the 97 largest listed companies in the UK and the Eurozone in 2010, only 37 had a COO in their executive ranks. Most COOs in Europe are seasoned executives; they were 48 years old, on average, when they were appointed.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

SEPTEMBER 13, 2012

Executives in many industries are putting plans into place to beef up their workforce's skills. As randomized testing and experimentation become more commonplace in the financial services, retail and pharmaceutical industries, a background in scientific experimental design will be particularly valued. Are you ready to join them?

Skills 17

Skills Pharmaceuticals Sample Business Intelligence 17

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

JULY 17, 2014

Similar reform in the relationship between marketing, finance and analytics is taking place across many sectors – from manufacturing and retail, to financial services, travel and entertainment, pharmaceuticals and toys. This has spurred re-thinks that include changes to key executive relationships.

Finance 13

Finance Marketing P&L ROI 13

Harvard Business Review

DECEMBER 27, 2016

Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. Core to the curriculum is emotional intelligence (with 360-degree feedback and executive coaching), teambuilding, conflict resolution, and situational leadership.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

SEPTEMBER 29, 2011

Not long ago, the chief executive of a global telecommunications firm shared with me his frustration that "even in a meeting with the CEO, most institutional investors seek only granular data points to plug into their models. This blog post is part of the HBR Online Forum The CEO's Role in Fixing the System.

Long-term 12

Long-term CEO Short-term Asset Management 12

Harvard Business Review

JANUARY 5, 2018

Although long ignored, these middle management positions have become increasingly recognized as critical to executing a company’s strategy. In sales-driven companies (think pharmaceuticals and industrial equipment), they are often field sales managers who direct dozens of salespeople in the highest-volume regions.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

NOVEMBER 15, 2018

As I speak with industry executives, a common refrain is “I’ve done all the easy stuff.” An investor-owned hospital executive whose company had acquired major nonprofit health care enterprises compared the proliferation of contracts to the growth of barnacles on the bottom of a freighter. cancel or rebid them).

Cost 10

Cost System Management Franchising 10

Harvard Business Review

JUNE 3, 2016

In fact, the relentless drive to embrace digital technologies has been ongoing for many decades. What also seems to have been forgotten are the lessons from these earlier attempts to leverage IT (remember that IT is a digital technology). The technologies and processes that are transforming companies. Insight Center.

Tools 8

Tools Supply Chain CRM Technology 8

Harvard Business Review

MAY 24, 2012

Pharmaceutical manufacturers, insurers, and retailers invest millions in risk avoidance. But in the era of Big Data and decision-making at the desktop, it's vexing to think that any company with significant technology investments would allow the all-too-human traits of ownership debates and subjective opinion to override robust data analysis.

Merchandising 10

Merchandising Risk Management Supply Chain Retail 10

Harvard Business Review

FEBRUARY 17, 2011

Nadathur's portfolio includes firms operating in drug discovery research, companion diagnostics, pharmaceutical analytics, reimbursement claims processing, patient relationship management, and specialty healthcare delivery for running clinical trials — and they all work together.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Strategy Driven

MARCH 18, 2011

Large downturns (such as this recession), technology disruptions, or regulatory shifts create discontinuities that simply accelerate the industry’s evolution toward this equilibrium state. They execute faster and with more force. The theoretical optimized industry is one with two or three players performing very different roles.

Resources 53

Resources Industry System Strategy 53

Harvard Business Review

MAY 10, 2016

As our research has shown us, the core of the problem is not the high number of M&A deals in itself, but rather that too many executives bring insufficient discipline to the evaluation process that fuels these deals — as a result, they often get deals wrong.

Strategy 8

Strategy Company Biotechnology Franchising 8

Strategy Driven

JANUARY 24, 2011

StrategyDriven effective executives, efficient employees Home About The StrategyDriven Organization Our Company Our Contributors Karen K. It’s that time of year again: time for business owners and senior executives to take stock of the past twelve months. Juliano Howard T. Dickens Jr. Ives Sharon Drew Morgen Hank Moore Jamie P.

Execution 68

Execution Company 360-Degree Feedback Cooper 68

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JANUARY 27, 2016

Because disruptive products were cheaper, more accessible, and built on new technology architectures, they tended to be crummier than the existing highest-end solutions. New technologies, combined with business model innovation, provide the structural cost advantage necessary to take large chunks of the market over time.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

MARCH 9, 2015

Advances in digital technology and their use in organizations carry huge promise to empower people at all levels. For example, a study of a multinational pharmaceutical company revealed that leaders in its U.S. Leadership & Managing people Technology Managing yourself'

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

SEPTEMBER 20, 2013

Fortunately, the organizations that took the effort to truly understand the value of their data were able to execute appropriately. Very importantly, they were able to avoid costly technology and implementation programs that would have surely fell short of usage and revenue expectations. This is easier said than done.

Execution 8

Execution Metrics Content Christensen 8